Bt Brinjal frozen until indpendent scientific study, says Ramesh

No clear consensus among the scientists and stake-holders, the minister says to put the decision on hold

PTI | February 9, 2010


File photo of Environment and Forests Minister Jairam Ramesh
File photo of Environment and Forests Minister Jairam Ramesh

Facing intense opposition from within and outside, government today refused to give a go-ahead to commercial cultivation of Bt Brinjal, a genetically-modified version of the vegetable that is said to be more resistant to pests.

Announcing a cautious approach of the government, Environment and Forests Minister Jairam Ramesh said there was "no clear consensus" among the scientists and stake-holders on giving permission to Bt Brinjal and more studies needed to be conducted.

"There is no over-riding urgency to introduce it... When the public sentiments have been negative, it is my duty to adopt a cautious, precautionary and principle-based approach," he told a hurriedly-called press conference which was originally scheduled for tomorrow.

"I will not impose a decision till such time independent scientific studies establish safety of the product from long-term view of human health," Ramesh said.

He said it was a difficult decision to take but he had to balance many issues of science and society and producer and consumer.

However, he made it clear that today's decision applied only to Bt Brinjal and does not cover future of genetically-modified crops, be it ladyfinger, cabbage or rice.

Ramesh's decision came after a series of public consultations in seven cities across the country, that often turned acrimonious. A number of state governments, including Congress-ruled Andhra Pradesh, have publicly opposed the introduction of Bt Brinjal.

Comments

 

Other News

Trump’s China setback pushes US to woo India

A week after Donald Trump’s visit to China – the first by an American president in nine years, US secretary of state Marco Rubio arrived in India on May 23 on a four-day visit aimed at resetting Washington DC’s relations with New Delhi and attending the third Quad ministerial meeting.

EU–India FTA 2026: A high‑stakes prescription for Indian pharma and healthcare

India’s pharmaceutical industry stands as one of the world’s market leaders of generic pharmacy with market valuation of USD 50 billion in 2026. Characterised by high volume, low-cost generic manufacturing, with an annual growth rate of 10-12% primarily propelled by exports and domestic demand,

Legends, vignettes and tales from the freedom movement

Robin Hood of Kathiawar and Other Extraordinary Stories from India’s Freedom Movement By The Paperclip  HarperCollins, 348 pages, Rs 499  

Solicitor General Tushar Mehta tells quirky tales from the world of law

The Lawful and the Awful: Quirky Tales from the World of Law By Tushar Mehta Rupa Publications, 336 pages, Rs 995  

Cabinet meet discussed `Ease of Living`, `Ease of Doing Business`

The Council of Ministers has deliberated upon valuable perspectives and best practices relating to boosting ‘Ease of Living’ and ‘Ease of Doing Business’, prime minister Narendra Modi said on Friday.   As he shared details of the Council meeting held the d

India should deepen energy partnerships with Africa

The vulnerability of Strait of Hormuz continues to influence energy politics globally. India is highly dependent on imported crude oil as a significant portion of its oil imports still come from the Gulf ultimately making such disruptions particularly consequential and has immediate economic ramifications


Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter